Understanding heterogeneity of human bone marrow plasma cell maturation and survival pathways by single-cell analyses

通过单细胞分析了解人类骨髓浆细胞成熟和存活途径的异质性

阅读:7
作者:Meixue Duan ,Doan C Nguyen ,Chester J Joyner ,Celia L Saney ,Christopher M Tipton ,Joel Andrews ,Sagar Lonial ,Caroline Kim ,Ian Hentenaar ,Astrid Kosters ,Eliver Ghosn ,Annette Jackson ,Stuart Knechtle ,Stalinraja Maruthamuthu ,Sindhu Chandran ,Tom Martin ,Raja Rajalingam ,Flavio Vincenti ,Cynthia Breeden ,Ignacio Sanz ,Greg Gibson ,F Eun-Hyung Lee

Abstract

Human bone marrow (BM) plasma cells are heterogeneous, ranging from newly arrived antibody-secreting cells (ASCs) to long-lived plasma cells (LLPCs). We provide single-cell transcriptional resolution of 17,347 BM ASCs from five healthy adults. Fifteen clusters are identified ranging from newly minted ASCs (cluster 1) expressing MKI67 and high major histocompatibility complex (MHC) class II that progress to late clusters 5-8 through intermediate clusters 2-4. Additional ASC clusters include the following: immunoglobulin (Ig) M predominant (likely of extra-follicular origin), interferon responsive, and high mitochondrial activity. Late ASCs are distinguished by G2M checkpoints, mammalian target of rapamycin (mTOR) signaling, distinct metabolic pathways, CD38 expression, utilization of tumor necrosis factor (TNF)-receptor superfamily members, and two distinct maturation pathways involving TNF signaling through nuclear factor κB (NF-κB). This study provides a single-cell atlas and molecular roadmap of LLPC maturation trajectories essential in the BM microniche. Altogether, understanding BM ASC heterogeneity in health and disease enables development of new strategies to enhance protective ASCs and to deplete pathogenic ones.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。